Publications by authors named "V Rodriguez-Vazquez"
Article Synopsis
- A study focused on patients with various Type 2 inflammation (T2i) diseases (like asthma and allergies) highlights the common challenges they face in terms of quality of life (QoL) and the limited understanding of their experiences and management needs.
- Conducted by the T2i Network Project, an anonymous online survey collected data from 404 participants, involving their demographics, disease severity, healthcare usage, and quality of care perceptions.
- Results showed that a significant portion of participants reported moderate-to-severe disease severity (93%), and those with multiple T2i conditions experienced a notably greater negative impact on their QoL compared to those with just one condition ( < .001).
Purpose: The objective of this study was to develop and validate a questionnaire, through a Delphi consensus, to be used by allergists in their routine clinical practice to assess the preferences of patients starting allergen immunotherapy (AIT) treatment using an objective approach.
Patients And Methods: A Delphi consensus-driven process was used. The scientific committee, composed of 15 allergists, led the study and participated in the preparation of the questionnaire.
Hymenoptera venom immunotherapy (HVI) is a long-term effective treatment to avoid new systemic reactions in patients with Hymenoptera allergy. The sting challenge test is considered the gold standard to confirm the tolerance. However, the use of this technique is not generalized in clinical practice, being the basophil activation test (BAT), which functionally explores allergen response, an alternative that does not entail any of the provocation risks associated with the sting challenge test.
View Article and Find Full Text PDF